| Active Pharmaceutical Ingredients (APIs) Manufacturing | Manufacture and supply of 80+ APIs including niche high-value products for global pharmaceutical companies. | Strong global regulatory approvals, diversified product portfolio, and large-scale multiproduct manufacturing plants. | B2B model serving global pharmaceutical manufacturers and distributors. | Niche APIs in therapeutic areas such as anti-infectives and neuromuscular drugs. | 1284 | 100 | Revenue primarily from sale of APIs and contract development and manufacturing services. | Contract-based supply with negotiated pricing suited for regulated pharmaceutical markets. | Regulatory approvals, expanded manufacturing capacity, and increasing global pharmaceutical demand. | |
